Brief: Sedana Medical: AnaConDa Approved For Use In Children
Sept 30 (Reuters) - Sedana Medical AB (publ) SEDANA.ST :
* ANACONDA APPROVED FOR USE IN CHILDREN
* APPROVAL FOR USE OF ANACONDA IN CHILDREN IS PREREQUISITE
FOR US
TO START OUR PEDIATRIC STUDY IN APRIL 2020
* APPROVAL FROM NOTIFYING BODY BSI GROUP
Source text for Eikon: ID:nWkr3X5n0n
Further company coverage: SEDANA.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com;))
Recent news on Sedana Medical AB (publ)
See all newsSweden's Sedana Medical Q3 sales rise as growth returns
Brief: Sedana Medical Announces PDUFA Target Action Date
Brief: Sedana Medical Announces FDA Acceptance For Review Of Its New Drug Application In U.S.
Sweden's Sedana Medical Q2 sales flat, EBITDA loss narrows
Brief: Sedana Medical Q2 EBITDA Loss Narrows To SEK 1.9 Mln